Evidence map›Paper›PMID 31614463›Full record

ArticleCancers2019

17

Natalia Vydra, Patryk Janus, Agnieszka Toma-Jonik, Tomasz Stokowy, Katarzyna Mrowiec, Joanna Korfanty, Anna Długajczyk, Bartosz Wojtaś, Bartłomiej Gielniewski, Wiesława Widłak

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Onco-Breastomics: An Eco-Evo-Devo Holistic Approach.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Heat Shock Proteins and HSF1 in Cancer.Frontiers in oncology · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Natalia VydraMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, 44-101 Gliwice, Wybrzeże Armii Krajowej 15, Poland. natalia.vydra@io.gliwice.pl.
Patryk JanusMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, 44-101 Gliwice, Wybrzeże Armii Krajowej 15, Poland. patryk.janus@io.gliwice.pl.
Agnieszka Toma-JonikMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, 44-101 Gliwice, Wybrzeże Armii Krajowej 15, Poland. agnieszka.toma-jonik@io.gliwice.pl.
Tomasz StokowyDepartment of Clinical Science, University of Bergen, Postboks 7800, 5020 Bergen, Norway. tomasz.stokowy@k2.uib.no.ORCID 0000-0003-0017-8338
Katarzyna MrowiecMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, 44-101 Gliwice, Wybrzeże Armii Krajowej 15, Poland. katarzyna.mrowiec@io.gliwice.pl.
Joanna KorfantyMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, 44-101 Gliwice, Wybrzeże Armii Krajowej 15, Poland. joanna.korfanty@io.gliwice.pl.ORCID 0000-0001-6942-9823
Anna DługajczykMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, 44-101 Gliwice, Wybrzeże Armii Krajowej 15, Poland. a.dlugajczyk@ibb.waw.pl.
Bartosz WojtaśLaboratory of Molecular Neurobiology, Neurobiology Center, Nencki Institute of Experimental Biology, PAS, 3 Pasteur Street, 02-093 Warsaw, Poland. b.wojtas@nencki.gov.pl.ORCID 0000-0002-9967-910X
Bartłomiej GielniewskiLaboratory of Molecular Neurobiology, Neurobiology Center, Nencki Institute of Experimental Biology, PAS, 3 Pasteur Street, 02-093 Warsaw, Poland. b.gielniewski@nencki.gov.pl.
Wiesława WidłakMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, 44-101 Gliwice, Wybrzeże Armii Krajowej 15, Poland. wieslawa.widlak@io.gliwice.pl.ORCID 0000-0002-8440-9414
The Maria Sklodowska-Curie National Research Institute of Oncology · PLInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLUniversity of Bergen · NO

Funding

Narodowe Centrum Nauki 2014/13/B/NZ7/02341Narodowe Centrum Nauki 2015/17/B/NZ3/03760
6 · The paper itself

Abstract

Heat Shock Factor 1 (HSF1) is a key regulator of gene expression during acute environmental stress that enables the cell survival, which is also involved in different cancer-related processes. A high level of HSF1 in estrogen receptor (ER)-positive breast cancer patients correlated with a worse prognosis. Here we demonstrated that 17

Indexed as

bisphenol AestrogenHeat Shock Factor 1MEK1/2xenoestrogen

Identifiers

PMID31614463
PMCPMC6826487
OpenAlexW2980049526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.